Literature DB >> 222444

Biological characterization of a leukemogenic virus isolated from the CFW mouse.

J K Ball, J A McCarter.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 222444

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  7 in total

Review 1.  Factors controlling the expression of mouse mammary tumour virus.

Authors:  W H Günzburg; B Salmons
Journal:  Biochem J       Date:  1992-05-01       Impact factor: 3.857

2.  Comparison of endogenous murine leukemia virus proviral organization and RNA expression in 3-methylcholanthrene-induced and spontaneous thymic lymphomas in RF and AKR mice.

Authors:  J Chinsky; M M Goodenow; M Jackson; F Lilly; L Leinwand; G Childs
Journal:  J Virol       Date:  1985-01       Impact factor: 5.103

3.  Selection for c-myc integration sites in polyclonal T-cell lymphomas.

Authors:  Dana R Broussard; Jennifer A Mertz; M Lozano; Jaquelin P Dudley
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

4.  The type B leukemogenic virus truncated superantigen is dispensable for T-cell lymphomagenesis.

Authors:  Farah Mustafa; Sanchita Bhadra; Dennis Johnston; Mary Lozano; Jaquelin P Dudley
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

5.  Integration of type B retroviral DNA in virus-induced primary murine thymic lymphomas.

Authors:  G A Dekaban; J K Ball
Journal:  J Virol       Date:  1984-12       Impact factor: 5.103

6.  Alterations in the U3 region of the long terminal repeat of an infectious thymotropic type B retrovirus.

Authors:  J K Ball; H Diggelmann; G A Dekaban; G F Grossi; R Semmler; P A Waight; R F Fletcher
Journal:  J Virol       Date:  1988-08       Impact factor: 5.103

7.  Promotional effects of azathioprine on peripheral B cell lymphomas in BALB/c mice induced by administration of 7,12-dimethylbenz[a]anthracene.

Authors:  K Fujiwara; T Yoshino; T Akagi; N Teramoto; K Hayashi
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.